期刊文献+

维生素D_3衍生物MART-10对人胰腺癌BxPC-3细胞的生长及survivinmRNA、c-myc蛋白、P21蛋白表达的影响 被引量:2

Effect of vitamin D_3 derivative MART-10 on cell growth and expression of survivin mRNA,c-myc protein and P21 protein in BxPC-3 cells
下载PDF
导出
摘要 目的:研究维生素D_3衍生物MART-10对人胰腺癌BxPC-3细胞的生长及survivin mRNA、c-myc蛋白、P21蛋白表达的影响,以期探讨其抑癌机制.方法:四甲基谷氮咪盐(methyl-thiazolyltetrazolium,MTT)比色法检测MART-10对BxPC-3细胞生长的影响;流式细胞术检测细胞周期,观察细胞的生长情况;逆转录-聚合酶链反应(reverse transcription-polymerase chain reaction,RT-PCR)法检测BxPC-3细胞中survivin mRNA的表达;Western blot法检测BxPC-3细胞中c-myc蛋白和P21蛋白的表达.结果:MTT结果显示,MART-10可显著抑制人胰腺癌BxPC-3细胞的生长,其抑制50%细胞生长的给药浓度(IC50)为10-7 mmol/L;流式细胞术结果显示,癌细胞在MART-10的作用下,G0/G1期的细胞比例上升而S期的细胞比例则下降;RT-PCR及Western blot结果表明,随着MART-10作用时间的延长及给药浓度的增加,胰腺癌BxPC-3细胞中survivin mRNA和c-myc蛋白的表达量逐渐减低,而P21蛋白的表达量则逐渐增强.结论:维生素D_3衍生物MART-10对人胰腺癌BxPC-3细胞的生长具有显著抑制作用,其作用的机制可能与其调节survivin、c-myc及P21的表达有关. AIM:To analyze the effect of MART-10,a new kind of vitamin D3 derivative,on cell growth and proliferation and the expression of survivin mRNA,c-myc protein and P21 protein in BxPC-3 cells.METHODS:After BxPC-3 cells were treated with MART-10,the growth of BxPC-3 cells was assessed by MTT assay,cell cycle was analyzed by flow cytometry,survivin mRNA level was detected by reverse transcription-polymerase chain reaction(RT-PCR),and c-myc and P21 protein expression was detected by Western blot.RESULTS:Treatment with MART-10 significantly inhibited the growth of BxPC-3cells,and the IC50 concentration was 10-7mmol/L.Flow cytometry results suggested that the proportion of S phase cells was decreased and the proportion of cells in G0/G1 phase was increased after treatment with MART-10.RT-PCR results showed that MART-10 significantly downregulated the mRNA level of survivin gene.Western blot results indicated that MART-10 significantly increased the protein levels of P21 but decreased the protein expression of c-myc.CONCLUSION:Our results suggest that MART-10 can effectively inhibit the growth and proliferation of BxPC-3 cells,and the mechanism may be related with its influence on the expression of survivin,c-myc and P21.
作者 杨晟 林军
出处 《世界华人消化杂志》 CAS 2016年第12期1860-1865,共6页 World Chinese Journal of Digestology
基金 湖北省自然科学基金资助项目 No.2014CFB747~~
关键词 维生素D3衍生物 BXPC-3细胞 SURVIVIN基因 C-MYC蛋白 P21蛋白 Vitamin D3 derivative BxPC-3 cells survivin gene c-myc protein P21
  • 相关文献

参考文献18

  • 1Chiang KC, Yeh CN, Hsu JT, Yeh TS, Jan YY, Wu CT, Chen HY, Jwo SC, Takano M, Kittaka A, Juang HH, Chen TC. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle 2013; 12: 1316-1325. 被引量:1
  • 2陈文浩,杨明,张艳桥.维生素D及其受体在胰腺癌中的研究进展[J].中国肿瘤,2015,24(4):307-313. 被引量:7
  • 3郑敏,刘强.维生素D及维生素D受体的研究进展[J].医学综述,2013,19(21):3965-3967. 被引量:24
  • 4Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA, Connor F, Van Dyke T, Kozlov S, Martin P, Tseng TW, Dawson DW, Donahue TR, Masamune A, Shimosegawa T, Apte MV, Wilson JS, Ng B, Lau SL, Gunton JE, Wahl GM, Hunter T, Drebin JA, O'Dwyer PJ, Liddle C, Tuveson DA, Downes M, Evans RM. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 2014; 159: 80-93. 被引量:1
  • 5Kennel KA, Drake MT. Vitamin D in the cancer patient. Curr Opin Support Palliat Care 2013; 7: 272-277. 被引量:1
  • 6崔健,陈虹,黄秉仁.维生素D受体最新研究进展[J].生理科学进展,2011,42(2):95-99. 被引量:45
  • 7Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 2012; 72: 1190-1198. 被引量:1
  • 8彭昌能,谷苗,李国庆.1,25(OH)_2D_3用于抗肿瘤的研究进展[J].中国现代医药杂志,2010,12(10):127-130. 被引量:13
  • 9Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014; 14: 342-357. 被引量:1
  • 10Chiang KC, Yeh CN, Hsu JT, Jan YY, Chen LW, Kuo SF, Takano M, Kittaka A, Chen TC, Chen WT, Pang JH, Yeh TS, Juang HH. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells. Cancer Lett 2014; 354: 235-244. 被引量:1

二级参考文献101

  • 1姜淑娟,王英田,白雪丽,李怀臣,陈方方.1,25二羟基维生素D_3对肺腺癌细胞株生长及凋亡的影响[J].肿瘤防治杂志,2005,12(20):1542-1545. 被引量:11
  • 2卢航青,郑杰.全反式维甲酸和1α,25二羟维生素D_3对肝癌细胞HepG2生长的协同抑制作用[J].癌症,2006,25(12):1470-1476. 被引量:12
  • 3Gao L,Tao Y,Zhang L,et al.Vitamin D receptor genetic polymorphisms and tuberculosis:updated systematic review and meta-analysis.Int J Tuberc Lung Dis,2010,14:15-23. 被引量:1
  • 4Kostner K,Denzer N,Muller CS,et al.The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer:a review of the literature.Anticancer Res,2009,29:3511-3536. 被引量:1
  • 5Yu XD,Shen XM,Xue MB,et al.Vitamin D receptor gene polymorphism and bone mineral density in 0-6-year-old Han children.J Bone Miner Metab,2011,29:54-61. 被引量:1
  • 6Matilainen JM,Malinen M,Turunen MM,et al.The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells.J Biol Chem,2010,285:24174-24183. 被引量:1
  • 7Nakabayashi M,Yamada S,Yoshimoto N,et al.Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs:structural basis for vitamin D receptor antagonism and partial agonism.J Med Chem,2008,51:5320-5329. 被引量:1
  • 8Teichert A,Arnold LA,Otieno S,et al.Quantification of the vitamin D receptor-coregulator interaction.Biochemistry,2009,48:1454-1461. 被引量:1
  • 9Oda Y,Sihlbom C,Chalkley RJ,et al.Two distinct coactivators,DRIP/mediator and SRC/p160,are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation.Mol Endocrinol,2003,17:2329-2339. 被引量:1
  • 10Zhang X,Dowd DR,Moore MC,et al.Meningioma 1 is required for appropriate osteoblast proliferation,motility,differentiation,and function.J Biol Chem,2009,284:18174-18183. 被引量:1

共引文献145

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部